YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)
Parker Waichman Alonso LLP Headlines by Topic
Aranesp
FDA panel wants more anemia drug studies
May 10, 2007 | AP
Two months after federal regulators ordered additional warnings be added to the labels of blockbuster anemia drugs, government advisers said Thursday...
FDA issues new warnings on anemia drugs
Mar 9, 2007 | AP
Federal health officials issued stern new warnings Friday for doctors to more carefully prescribe widely used anemia drugs that can increase the risk...
FDA Strengthens Safety Information for Erythropoiesis-Stimulating Agents (ESAs)
Mar 9, 2007 | www.fda.gov
The U.S. Food and Drug Administration (FDA) today issued a public health advisory outlining new safety information, including revised product...
FDA Warns of Serious Side Effects Related to Popular Anemia Drugs
Mar 9, 2007 | NewsInferno.com
FDA Warns of Serious Side Effects Related to Popular Anemia DrugsThe U.S. Food and Drug Administration (FDA) has issued a new warning about...
Amgen’s Anemia Drug Aranesp Carries Risk in Cancer Patients
Jan 29, 2007 | NewsInferno.com
In a letter sent last week to medical professionals and posted by the U.S. Food and Drug Administration (FDA), drug maker Amgen warned of an elevated...
Amgen’s Anemia Drug Aranesp Carries Risk in Cancer Patients
Jan 29, 2007 | NewsInferno.com
In a letter sent last week to medical professionals and posted by the U.S. Food and Drug Administration (FDA), drug maker Amgen warned of an elevated...
Amgen’s Anemia Drug Aranesp Carries Risk in Cancer Patients
Jan 29, 2007 | NewsInferno.com
In a letter sent last week to medical professionals and posted by the U.S. Food and Drug Administration (FDA), drug maker Amgen warned of an elevated...
Amgen’s Anemia Drug Aranesp Carries Risk in Cancer Patients
Jan 29, 2007 | NewsInferno.com
In a letter sent last week to medical professionals and posted by the U.S. Food and Drug Administration (FDA), drug maker Amgen warned of an elevated...
Aranesp (Darbepoetin Alfa) - Warnings Revised to Include Reports of Increased Mortality and Thrombotic Vascular Events
Jan 13, 2005 | www.pharmalive.com
FDA and Amgen notified healthcare professionals of revisions to the WARNINGS and PRECAUTIONS sections of the prescribing information for Aranesp,...
Aranesp
